Global Clinical Trials Imaging Market Research Report 2023

Publication ID:

PB504234298

Publication Date:

April 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Highlights
The global Clinical Trials Imaging market was valued at US$ 1495.2 million in 2022 and is anticipated to reach US$ 2281.9 million by 2029, witnessing a CAGR of 7.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trials Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trials Imaging.
The Clinical Trials Imaging market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Clinical Trials Imaging market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trials Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bioclinica
Parexel International
Radiant Sage
Biomedical Systems
Biotelemetry
Icon
IXICO
Cardiovascular Imaging Technologies
Intrinsic Imaging
Worldcare Clinical
Virtualscopics
Segment by Type
Computed Tomography
Ultrasound
Echocardiography
Magnetic Resonance Imaging
Positron Emission Tomography
X-Ray
Other Modalities
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Medical Device Manufacturers
Academic and Government Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trials Imaging companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trials Imaging Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Computed Tomography
1.2.3 Ultrasound
1.2.4 Echocardiography
1.2.5 Magnetic Resonance Imaging
1.2.6 Positron Emission Tomography
1.2.7 X-Ray
1.2.8 Other Modalities
1.3 Market by Application
1.3.1 Global Clinical Trials Imaging Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Contract Research Organizations
1.3.5 Medical Device Manufacturers
1.3.6 Academic and Government Research Institutes
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trials Imaging Market Perspective (2018-2029)
2.2 Clinical Trials Imaging Growth Trends by Region
2.2.1 Global Clinical Trials Imaging Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trials Imaging Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trials Imaging Forecasted Market Size by Region (2024-2029)
2.3 Clinical Trials Imaging Market Dynamics
2.3.1 Clinical Trials Imaging Industry Trends
2.3.2 Clinical Trials Imaging Market Drivers
2.3.3 Clinical Trials Imaging Market Challenges
2.3.4 Clinical Trials Imaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trials Imaging Players by Revenue
3.1.1 Global Top Clinical Trials Imaging Players by Revenue (2018-2023)
3.1.2 Global Clinical Trials Imaging Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trials Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trials Imaging Revenue
3.4 Global Clinical Trials Imaging Market Concentration Ratio
3.4.1 Global Clinical Trials Imaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trials Imaging Revenue in 2022
3.5 Clinical Trials Imaging Key Players Head office and Area Served
3.6 Key Players Clinical Trials Imaging Product Solution and Service
3.7 Date of Enter into Clinical Trials Imaging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trials Imaging Breakdown Data by Type
4.1 Global Clinical Trials Imaging Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trials Imaging Forecasted Market Size by Type (2024-2029)
5 Clinical Trials Imaging Breakdown Data by Application
5.1 Global Clinical Trials Imaging Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trials Imaging Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trials Imaging Market Size (2018-2029)
6.2 North America Clinical Trials Imaging Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Clinical Trials Imaging Market Size by Country (2018-2023)
6.4 North America Clinical Trials Imaging Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trials Imaging Market Size (2018-2029)
7.2 Europe Clinical Trials Imaging Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Clinical Trials Imaging Market Size by Country (2018-2023)
7.4 Europe Clinical Trials Imaging Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trials Imaging Market Size (2018-2029)
8.2 Asia-Pacific Clinical Trials Imaging Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Clinical Trials Imaging Market Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Trials Imaging Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trials Imaging Market Size (2018-2029)
9.2 Latin America Clinical Trials Imaging Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Clinical Trials Imaging Market Size by Country (2018-2023)
9.4 Latin America Clinical Trials Imaging Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trials Imaging Market Size (2018-2029)
10.2 Middle East & Africa Clinical Trials Imaging Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Clinical Trials Imaging Market Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Trials Imaging Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioclinica
11.1.1 Bioclinica Company Detail
11.1.2 Bioclinica Business Overview
11.1.3 Bioclinica Clinical Trials Imaging Introduction
11.1.4 Bioclinica Revenue in Clinical Trials Imaging Business (2018-2023)
11.1.5 Bioclinica Recent Development
11.2 Parexel International
11.2.1 Parexel International Company Detail
11.2.2 Parexel International Business Overview
11.2.3 Parexel International Clinical Trials Imaging Introduction
11.2.4 Parexel International Revenue in Clinical Trials Imaging Business (2018-2023)
11.2.5 Parexel International Recent Development
11.3 Radiant Sage
11.3.1 Radiant Sage Company Detail
11.3.2 Radiant Sage Business Overview
11.3.3 Radiant Sage Clinical Trials Imaging Introduction
11.3.4 Radiant Sage Revenue in Clinical Trials Imaging Business (2018-2023)
11.3.5 Radiant Sage Recent Development
11.4 Biomedical Systems
11.4.1 Biomedical Systems Company Detail
11.4.2 Biomedical Systems Business Overview
11.4.3 Biomedical Systems Clinical Trials Imaging Introduction
11.4.4 Biomedical Systems Revenue in Clinical Trials Imaging Business (2018-2023)
11.4.5 Biomedical Systems Recent Development
11.5 Biotelemetry
11.5.1 Biotelemetry Company Detail
11.5.2 Biotelemetry Business Overview
11.5.3 Biotelemetry Clinical Trials Imaging Introduction
11.5.4 Biotelemetry Revenue in Clinical Trials Imaging Business (2018-2023)
11.5.5 Biotelemetry Recent Development
11.6 Icon
11.6.1 Icon Company Detail
11.6.2 Icon Business Overview
11.6.3 Icon Clinical Trials Imaging Introduction
11.6.4 Icon Revenue in Clinical Trials Imaging Business (2018-2023)
11.6.5 Icon Recent Development
11.7 IXICO
11.7.1 IXICO Company Detail
11.7.2 IXICO Business Overview
11.7.3 IXICO Clinical Trials Imaging Introduction
11.7.4 IXICO Revenue in Clinical Trials Imaging Business (2018-2023)
11.7.5 IXICO Recent Development
11.8 Cardiovascular Imaging Technologies
11.8.1 Cardiovascular Imaging Technologies Company Detail
11.8.2 Cardiovascular Imaging Technologies Business Overview
11.8.3 Cardiovascular Imaging Technologies Clinical Trials Imaging Introduction
11.8.4 Cardiovascular Imaging Technologies Revenue in Clinical Trials Imaging Business (2018-2023)
11.8.5 Cardiovascular Imaging Technologies Recent Development
11.9 Intrinsic Imaging
11.9.1 Intrinsic Imaging Company Detail
11.9.2 Intrinsic Imaging Business Overview
11.9.3 Intrinsic Imaging Clinical Trials Imaging Introduction
11.9.4 Intrinsic Imaging Revenue in Clinical Trials Imaging Business (2018-2023)
11.9.5 Intrinsic Imaging Recent Development
11.10 Worldcare Clinical
11.10.1 Worldcare Clinical Company Detail
11.10.2 Worldcare Clinical Business Overview
11.10.3 Worldcare Clinical Clinical Trials Imaging Introduction
11.10.4 Worldcare Clinical Revenue in Clinical Trials Imaging Business (2018-2023)
11.10.5 Worldcare Clinical Recent Development
11.11 Virtualscopics
11.11.1 Virtualscopics Company Detail
11.11.2 Virtualscopics Business Overview
11.11.3 Virtualscopics Clinical Trials Imaging Introduction
11.11.4 Virtualscopics Revenue in Clinical Trials Imaging Business (2018-2023)
11.11.5 Virtualscopics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Bioclinica
Parexel International
Radiant Sage
Biomedical Systems
Biotelemetry
Icon
IXICO
Cardiovascular Imaging Technologies
Intrinsic Imaging
Worldcare Clinical
Virtualscopics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂